PYPD: PolyPid Limited Company Aggregate Debts

The debt burden dynamics of PolyPid Ltd. (PYPD), which utilizes the PLEXEL polymer system to combat surgical infections, demonstrate that the 0.00 level is a current figure. The firm's prospects rely on insurance payouts and the success of clinical trials. Meanwhile, the business operates in an autonomous cycle, rendering the asset resilient to global economic downturns.

PolyPid Ltd - PYPD Company Debts (period 07/04/2022 - 10/27/2026)

Analytical breakdowns and data insights for company PolyPid Ltd. (PYPD)

- price and consensus price forecast:

Price Performance Chart polypid.com|PYPD - Analyst Consensus Forecast

- market capitalization data:

Market Capitalization PolyPid Limited|PYPD - Total Company Value

- book capitalization data:

Accounting Value of a Share PolyPid|PYPD - Company Book Value|Market Cap to Net Assets Ratio polypid.com|PYPD - Company Total Assets

- debt and liquidity data:

Total Debt to Capital PolyPid Ltd.|PYPD - Long-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital polypid.com|PYPD - Company Aggregate Debts|Debts to Net Assets PolyPid Limited

Summary company analysis:PolyPid Ltd PYPD

This indicator measures total liabilities, allowing for an assessment of the balance between financial stability and the use of a tax shield to optimize return on equity. By analyzing the total debt history, an investor determines the ability of PolyPid Ltd. (PYPD) to finance the expansion of the D-PLEX system without a critical debt load, confirming the viability of the commercialization strategy for its innovative antibacterial surgical product.

Competitors of PolyPid Ltd. (PYPD)